Skip to main content
SpringerLink
Log in

Sustained oral lysine supplementation in ornithine δ-aminotransferase deficiency

  • Published:
Journal of Inherited Metabolic Disease

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  • Peltola K, Heinonen OJ, Nanto-Salonen K, Pulkki K, Simmel O (2000) Oral lysine feeding in gyrate atrophy with hyperornithinaemia—a pilot study. J Inherit Metab Dis 23: 305-307.

    Google Scholar 

  • Valle D, Simell O (1995) The hyperornithinemias. In Scriver C, Beaudet A, Sly W, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 1147-1185.

    Google Scholar 

  • Wang T, Steel G, Milam AH, Valle D (2000) Correction of ornithine accumulation prevents retinal degeneration in a mouse model of gyrate atrophy of the choroid and retina. Proc Natl Acad Sci USA 97: 1224-1229.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Metabolic Disease Unit, Shaare-Zedek Medical Center, Jerusalem

    O. N. Elpeleg

  2. Department of Clinical Biochemistry, Hadassah University Hospital, Jerusalem, Israel

    S. H. Korman

Authors
  1. O. N. Elpeleg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. H. Korman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Elpeleg, O.N., Korman, S.H. Sustained oral lysine supplementation in ornithine δ-aminotransferase deficiency. J Inherit Metab Dis 24, 423–424 (2001). https://doi.org/10.1023/A:1010545811361

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1010545811361

Keywords

Search

Navigation